Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could squeeze future profitability. During the fourth quarter, Masimo earned an ...

Masimo is up 10.4% since the beginning of the year, and at $186.09 per share, has set a new 52-week high. Investors who bought $1,000 worth of Masimo’s shares 5 years ago would now be looking at ...

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 earnings beat. The company is moving quickly with ...

Piper Sandler analyst Jason Bednar raised the firm’s price target on Masimo (MASI) to $215 from $210 and keeps an Overweight rating on the shares. The firm notes the company announced Q4 revenue ...

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors ...